Arrigo Francesco Giuseppe Cicero
Overview
Explore the profile of Arrigo Francesco Giuseppe Cicero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
588
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fogacci F, Borghi C, Cicero A
Nutrients
. 2024 Sep;
16(18).
PMID: 39339749
Atherosclerotic cardiovascular diseases (ASCVDs) remain leading causes of mortality and disability in Western countries [...].
2.
Pappaccogli M, Ponsa L, Goi J, Burrello J, Di Dalmazi G, Cicero A, et al.
High Blood Press Cardiovasc Prev
. 2024 Sep;
31(5):501-512.
PMID: 39292380
Introduction: Renovascular hypertension (RVH) remains underdiagnosed despite its significant cardiovascular and renal morbidity. Aim: This survey investigated screening and management practices for RVH among hypertensive patients in Italian hypertension centres...
3.
Foroutan Z, Cicero A, Jamialahmadi T, Sahebkar A
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Sep;
398(2):1299-1304.
PMID: 39287673
Necroptosis is an emerging form of programmed cell death characterized by necrosis, an inflammatory type of cell death. Necroptosis is primarily initiated by specific mediators that interact with receptor proteins,...
4.
Fogacci F, Giovannini M, Di Micoli V, Grandi E, Borghi C, Cicero A
Nutrients
. 2024 Aug;
16(15).
PMID: 39125336
Postbiotics could exert different metabolic activities in animal models of non-alcoholic fatty liver disease (NAFLD) and in humans affected by metabolic syndrome. This is a randomized, double-blind, placebo-controlled, parallel-group clinical...
5.
Barrea L, Caprio M, Grassi D, Cicero A, Bagnato C, Paolini B, et al.
Curr Nutr Rep
. 2024 Jul;
13(3):552-556.
PMID: 39039372
Purpose Of Review: In an attempt to clarify the most appropriate nomenclature for the very low-calorie ketogenic diets (VLCKD), we propose to change the nomenclature and acronym of this medical...
6.
Agabiti Rosei C, Paini A, Buso G, Maloberti A, Giannattasio C, Salvetti M, et al.
Metabolites
. 2024 Jun;
14(6).
PMID: 38921458
High levels of serum uric acid (SUA) and triglycerides (TG) might promote high-cardiovascular-risk phenotypes, including subclinical atherosclerosis. An interaction between plaques xanthine oxidase (XO) expression, SUA, and HDL-C has been...
7.
Fogacci F, AlGhasab N, Di Micoli V, Giovannini M, Cicero A
Nutrients
. 2024 May;
16(10).
PMID: 38794764
Long-term exposure to even slightly elevated plasma cholesterol levels significantly increases the risk of developing cardiovascular disease. The latest evidence recommends an improvement in plasma lipid levels, even in children...
8.
Maloberti A, Mengozzi A, Russo E, Cicero A, Angeli F, Agabiti Rosei E, et al.
High Blood Press Cardiovasc Prev
. 2023 Oct;
30(5):411-425.
PMID: 37792253
The relationship between Serum Uric Acid (UA) and Cardiovascular (CV) diseases has already been extensively evaluated, and it was found to be an independent predictor of all-cause and cardiovascular mortality...
9.
Gallo G, Sarzani R, Cicero A, Genovese S, Pirro M, Gallelli L, et al.
High Blood Press Cardiovasc Prev
. 2023 Apr;
30(2):83-91.
PMID: 37020154
Current cardiovascular disease prevention strategies are based on the management of cardiovascular risk as a continuum, redefining the therapeutic goals for each individual based on the estimated global risk profile....
10.
Orlando L, Bagnato G, Ioppolo C, Franze M, Perticone M, Versace A, et al.
Biomedicines
. 2023 Mar;
11(3).
PMID: 36979918
Background: During the SARS-CoV-2 pandemic, several biomarkers were shown to be helpful in determining the prognosis of COVID-19 patients. The aim of our study was to evaluate the prognostic value...